The history of antimicrobial resistance (AMR) evolution and the diversity of the
environmental resistome indicate that AMR is an ancient natural phenomenon. Acquired …

Bacterial infectious diseases are one of the leading causes of death worldwide. Even with
the use of multiple antibiotic treatment strategies, 4.95 million people died from drug …

For the first time since 2015, the World Health Organization's (WHO) global Antimicrobial
Resistance and Use Surveillance (GLASS) featured both global reports for antimicrobial …

Antibiotic resistance is an urgent public health threat that has received substantial attention
from the world's leading health agencies and national governmental bodies alike. However …

Antimicrobial peptides (AMPs) are a promising alternative to classical antibiotics in the fight
against multi-resistant bacteria. They are produced by organisms from all domains of life and …

Pseudomonas aeruginosa infections can be difficult to treat and new therapeutics are
needed. Bacteriophage therapy is a promising alternative to traditional antibiotics, but large …

Summary In this Personal View, we critically examine the wider context of international
efforts to stimulate commercial antibiotic research and development via public–private …

The social organisation of economic life plays a pivotal role in assembling many emerging
and enduring health problems. Yet throughout the recent history of global health challenges …

The COVID-19 pandemic has underlined the importance of an efficient and equitable supply
of and access to essential health products. These factors are equally pertinent to the …

Background Bacterial biofilm formation is a complicating factor in the antimicrobial treatment
of bacterial infections. Objectives In this study, we assessed the impact of a novel hydrogel …